+39 02 610346.1 - info@newron.com

Latest press releases

  • 16Jan
    Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for PD in Canada

  • 30Nov
    Zambon announces approval and ARTG listing of safinamide in Australia for treatment of patients with Parkinson’s disease


  • 31Oct
    Newron Pharmaceuticals hosts its 2018 R&D Day in New York City

  • 30Oct
    Investment Plan for Europe: EIB backs Italian CNS drug developer Newron Pharmaceuticals with up to EUR 40m


  • 23Oct
    Meiji Seika and Eisai announce submission of manufacturing and marketing approval application in Japan for safinamide in Parkinson’s disease

  • 15Oct
    Newron Pharmaceuticals Announces Prominent Medical Experts to Present at its 2018 R&D Day on October 31 in New York


View All

Newron share price


  • 27Feb
    2019 Leerink Partners Gloal Healthcare Conference

    February 27 - March 1, 2019 - Lotte New York Palace Hotel, New York, USA

  • 11Feb
    BIO CEO & Investor Conference 2019

    February 11-12, 2019 - Marriott Marquis, New York, NY, USA

  • 7Jan
    J.P. Morgan 37th Annual Healthcare Conference 2019

    January 7-10, 2019 - San Francisco, CA, USA

View Event Calendar